These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9433335)

  • 21. Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates.
    Kulhara P; Basu D; Mattoo SK; Sharan P; Chopra R
    J Affect Disord; 1999 Jul; 54(1-2):87-96. PubMed ID: 10403151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders.
    Tondo L; Baldessarini RJ; Hennen J; Floris G
    Am J Psychiatry; 1998 May; 155(5):638-45. PubMed ID: 9585715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode.
    Keck PE; McElroy SL; Strakowski SM; West SA; Sax KW; Hawkins JM; Bourne ML; Haggard P
    Am J Psychiatry; 1998 May; 155(5):646-52. PubMed ID: 9585716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing recurrence of bipolar I mood episodes and hospitalizations: family psychotherapy plus pharmacotherapy versus pharmacotherapy alone.
    Solomon DA; Keitner GI; Ryan CE; Kelley J; Miller IW
    Bipolar Disord; 2008 Nov; 10(7):798-805. PubMed ID: 19032711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Course and outcome in bipolar affective disorder: a longitudinal follow-up study.
    Goldberg JF; Harrow M; Grossman LS
    Am J Psychiatry; 1995 Mar; 152(3):379-84. PubMed ID: 7864263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is clozapine a mood stabilizer?
    Zarate CA; Tohen M; Banov MD; Weiss MK; Cole JO
    J Clin Psychiatry; 1995 Mar; 56(3):108-12. PubMed ID: 7883728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
    Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
    Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lithium levels and psychosocial function in patients with bipolar I disorder.
    Solomon DA; Ristow WR; Keller MB; Kane JM; Gelenberg AJ; Rosenbaum JF; Warshaw MG
    Am J Psychiatry; 1996 Oct; 153(10):1301-7. PubMed ID: 8831438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis.
    Chand PK; Mattoo SK; Sharan P
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):311-8. PubMed ID: 15149299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome in manic disorders. A naturalistic follow-up study.
    Harrow M; Goldberg JF; Grossman LS; Meltzer HY
    Arch Gen Psychiatry; 1990 Jul; 47(7):665-71. PubMed ID: 2113802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium discontinuers. II. Therapeutic outcome.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1991 Jul; 84(1):78-82. PubMed ID: 1681682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of lithium prophylaxis in bipolar patients.
    Maj M; Pirozzi R; Kemali D
    Arch Gen Psychiatry; 1991 Aug; 48(8):772. PubMed ID: 1909111
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.
    Tondo L; Baldessarini RJ; Floris G; Rudas N
    Am J Psychiatry; 1997 Apr; 154(4):548-50. PubMed ID: 9090344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The likelihood of recurrence in bipolar affective disorder: the importance of episode recency.
    Coryell W; Endicott J; Maser JD; Mueller T; Lavori P; Keller M
    J Affect Disord; 1995 Mar; 33(3):201-6. PubMed ID: 7790673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Bryan AL; Ali SO; Post RM
    Am J Psychiatry; 1997 Oct; 154(10):1456-8. PubMed ID: 9326833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients.
    Peselow ED; Dunner DL; Fieve RR; Lautin A
    Am J Psychiatry; 1982 Jun; 139(6):747-52. PubMed ID: 6805339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients.
    Maj M; Pirozzi R; Starace F
    J Affect Disord; 1989; 17(3):237-41. PubMed ID: 2529291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.